Clinical Trial Update: Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of romosozumab compared with bisphosphonates in children and adolescents with osteogenesis imperfect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Bisphosphonates (bisphosphonate)
• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Osteogenesis Imperfecta | Phase 3 | Status: RECRUITING